Uncommon
PrivateLast Round
Series A
Jun 9, 2023
Total Funding Raised
$33.77M
Company Overview
Uncommon operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Series A round in June 2023.
Uncommon is a biotechnology company that developed RNA-based technology for cultivated meat production before pivoting to focus on programmable RNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Uncommon Comparables
Compare Uncommon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eleven Therapeutics | 58% | |
| CamGene Therapeutics | 58% | |
| SymphoRNA | 58% |
For institutional investors. Book with your work email.
Uncommon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 9, 2023 | ||||
| Grant | Feb 1, 2021 | ||||
| Seed | Jan 1, 2020 | ||||
| Pre Seed | Nov 1, 2018 |
For institutional investors. Book with your work email.
Uncommon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| East Alpha | Series A |
| Lowercarbon Capital | Series A |
| Balderton Capital | Series A |
| Redalpine | Series A |
Uncommon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Uncommon's valuation, stock price, and market status.
Is Uncommon a public or private company?
Uncommon is a private company.
What is the current stock price of Uncommon?
Uncommon is a private company, so its shares have no public market price. Caplight tracks Uncommon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Uncommon worth (valuation)?
Valuation information for Uncommon is not publicly available.
Can I buy Uncommon stock?
Uncommon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Uncommon's last funding round?
Uncommon's most recent funding round was Series A on June 9, 2023.
Who are the main investors in Uncommon?
Key investors in Uncommon include Innovate UK, Lowercarbon Capital, Balderton Capital.
Will Uncommon IPO soon?
No public IPO plans have been announced for Uncommon.
How can I track Uncommon secondary market activity?
Caplight tracks bids, offers, and trades in Uncommon's shares on secondary markets.